Ultrasonography in Juvenile Idiopathic Arthritis
Changes in Joint-Cartilage as a Measure of Outcome in Juvenile Idiopathic Arthritis - Assessed by Ultrasonography and Biomarkers
1 other identifier
observational
95
1 country
1
Brief Summary
The purpose of this study is to analyse the usability of ultrasonography together with biomarkers in the investigation of patients diagnosed with juvenile idiopathic arthritis. The investigators hypothesize that serum and urine markers of cartilage and bone synthesis and degradation, together with ultrasound measurements of joint cartilage thickness, are useful tools in the early evaluation of JIA patients, - as diagnostic, prognostic and monitoring methods.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Oct 2009
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2009
CompletedFirst Submitted
Initial submission to the registry
January 7, 2011
CompletedFirst Posted
Study publicly available on registry
February 25, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2011
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2011
CompletedMarch 22, 2012
March 1, 2012
2.1 years
January 7, 2011
March 21, 2012
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Joint cartilage thickness
Joint catilage thickness measured by ultrasonography: knee, ankle, wrist, metacarpophalangeal and proximal interphalangeal joints by MRI: one knee by plain radiographs: knee, ankel and wrist
1.5 years
Secondary Outcomes (1)
Level of different biomarkers in serum and urine
1.5 years
Interventions
Scanning 5 joints bilaterally with an ultrasound scanner
Eligibility Criteria
Children diagnosed with Juvenile Idiopathic Arthritis, followed in dept of pediatric rheumatology, Aarhus University Hospital, Skejby
You may qualify if:
- Juvenile idiopathic arthritis: Oligoarticular, polyarticular or systemic onset type.
- Informed consent from parents
- between 5-15 years of age
You may not qualify if:
- Other diagnoses that involves bones or cartilage
- Intraarticular steroid injections within 1 month of the trial investigation
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Aarhuslead
- Aarhus University Hospitalcollaborator
Study Sites (1)
Pediatric research dept, Aarhus Universityhospital, Skejby
Aarhus, Region Midt, 8200, Denmark
Biospecimen
Serum specimens taken for rutine markers of inflammation.
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 7, 2011
First Posted
February 25, 2011
Study Start
October 1, 2009
Primary Completion
November 1, 2011
Study Completion
November 1, 2011
Last Updated
March 22, 2012
Record last verified: 2012-03